Interview with Dr. Aaron Muth
By: Rosa Kang PharmD Candidate c/o 2027 Dr. Aaron Muth, Ph.D., is currently an Associate Professor in the Department of…
How Political Changes Are Reshaping the Pharmaceutical Industry in 2025
By: Nivaj Haque PharmD Candidate c/o 2027 The pharmaceutical industry is undergoing significant changes in the background as new government…
FDA Approves First Oral Liquid Imatinib for Certain Cancers
By Amanda Nakhul, Biomedical Sciences c/o 2027 Precision is key in multiple aspects of our lives, including medicine. Diseases such…
FDA Approves New Schizophrenia Drug with New Mechanism of Action
By Ansha Hamid PharmD Candidate c/o 2027 Schizophrenia is a severe mental illness that is described by a list of…
The FDA’s Red Dye No. 3 Ban: Its Far-reaching Impact on Public Health, Pharmacies, and the Pharmaceutical Industry
By: Sariah Grant PharmD Candidate c/o 2027 Color additives have long played a crucial role in the appearance and appeal…
FDA Approval of Landiolol (Rapiblyk) for Supraventricular Tachycardia
By: Nivaj Haque; PharmD Candidate c/o 2027 Recent advancements in cardiology have revolutionized the management of arrhythmias, offering new hope…
What is the best price to use for pharmacoeconomic purposes?
By: Farzana Alam, PharmD Candidate c/o 2025, Anthony Autera, PharmD Candidate c/o 2025, Maha Saad, PharmD Background Drug pricing metrics…
Clearing the Air: FDA Proposes to Sniff Out Phenylephrine from OTC Shelves
By: Christine Mauceri, PharmD Candidate c/o 2025 On November 7th, 2024, the Food and Drug Administration (FDA) announced its proposal…
Oxbryta’s Journey: From Accelerated Approval to Market Withdrawal
By: Amita Singh, Pharm D Candidate c/o 2025 Voxelotor, marketed under the brand name Oxbryta, was approved by the US.…
FDA Approves First Nasal Spray for Treatment of Anaphylaxis
By: Rebecca Sabzanov, PharmD Candidate c/o 2026 On August 9th, 2024, the Food and Drug Administration (FDA) approved Neffy, the…